GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▼ |
---|---|---|---|
1RMG | A55415 | RHAMNOGALACTURONASE A FROM ASPERGILLUS ACULEATUS | RHAMNOGALACTURONASE A |
1DEO | Q00017 | RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.55 A RESOLUTION WITH SO4 IN THE ACTIVE SITE | RHAMNOGALACTURONAN ACETYLESTERASE |
1DEX | Q00017 | RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.9 A RESOLUTION | RHAMNOGALACTURONAN ACETYLESTERASE |
4LEO | 4LEO | Crystal structure of anti-HER3 Fab RG7116 in complex with the extracellular domains of human Her3 (ERBB3) | RG7116 Fab heavy chain, RG7116 Fab light chain, Receptor tyrosine-protein kinase erbB-3 (E.C.2.7.10.1) |
4LEO | P21860 | Crystal structure of anti-HER3 Fab RG7116 in complex with the extracellular domains of human Her3 (ERBB3) | RG7116 Fab heavy chain, RG7116 Fab light chain, Receptor tyrosine-protein kinase erbB-3 (E.C.2.7.10.1) |
1HRN | P00797 | HIGH RESOLUTION CRYSTAL STRUCTURES OF RECOMBINANT HUMAN RENIN IN COMPLEX WITH POLYHYDROXYMONOAMIDE INHIBITORS | RENIN COMPLEXED WITH POLYHYDROXYMONOAMIDE INHIBITOR BILA 980 |
2REN | P00797 | STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION | RENIN (E.C.3.4.23.15) |
2V0Z | P00797 | Crystal Structure of Renin with Inhibitor 10 (Aliskiren) | RENIN (E.C.3.4.23.15) |
1RNE | P00797 | THE CRYSTAL STRUCTURE OF RECOMBINANT GLYCOSYLATED HUMAN RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG INHIBITOR | RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.C.3.4.23.15) COMPLEX WITH CGP 38'560 |
2C9A | P28827 | Crystal structure of the MAM-Ig module of receptor protein tyrosine phosphatase mu | RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE MU (E.C.3.1.3.48) |
5FN7 | P08575 | Crystal structure of human CD45 extracellular region, domains d1-d2 | RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE C (E.C.3.1.3.48) |
5FN8 | P04157 | Crystal structure of rat CD45 extracellular region, domains d3-d4 | RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE C (E.C.3.1.3.48) |
6ORO | 6ORO | Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab874NHP | RC1 variant of HIV-1 Env glycoprotein gp41, RC1 variant of HIV-1 Env glycoprotein gp120, Ab874NHP antibody Fab heavy chain, Ab874NHP antibody Fab light chain |
6UDK | S6B2B6 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | 6UDK | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | S6B2B6 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | 6UDK | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | Q8N355 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | Q8N355 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | S6C4S0 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | S6C4S0 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | Q6PJF2 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6UDK | Q6PJF2 | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
6CXC | P03420 | 3.9A Cryo-EM structure of murine antibody bound at a novel epitope of respiratory syncytial virus fusion protein | R4.C6 Fab Heavy Chain, R4.C6 Fab Light Chain, Fusion glycoprotein F0,Envelope glycoprotein |
6CXC | M1E1E4 | 3.9A Cryo-EM structure of murine antibody bound at a novel epitope of respiratory syncytial virus fusion protein | R4.C6 Fab Heavy Chain, R4.C6 Fab Light Chain, Fusion glycoprotein F0,Envelope glycoprotein |
6CXC | 6CXC | 3.9A Cryo-EM structure of murine antibody bound at a novel epitope of respiratory syncytial virus fusion protein | R4.C6 Fab Heavy Chain, R4.C6 Fab Light Chain, Fusion glycoprotein F0,Envelope glycoprotein |
1GQG | 1GQG | Quercetin 2,3-dioxygenase in complex with the inhibitor diethyldithiocarbamate | QUERCETIN 2,3-DIOXYGENASE (E.C.1.13.11.24) |
1GQH | 1GQH | Quercetin 2,3-dioxygenase in complex with the inhibitor kojic acid | QUERCETIN 2,3-DIOXYGENASE (E.C.1.13.11.24) |
1H1I | Q7SIC2 | CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE ANAEROBICALLY COMPLEXED WITH THE SUBSTRATE QUERCETN | QUERCETIN 2,3-DIOXYGENASE (E.C.1.13.11.24) |
1H1M | Q7SIC2 | CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE ANAEROBICALLY COMPLEXED WITH THE SUBSTRATE KAEMPFEROL | QUERCETIN 2,3-DIOXYGENASE (E.C.1.13.11.24) |
5LNS | Q8L940 | Crystal structure of Arabidopsis thaliana Pdx1-R5P complex | Pyridoxal 5'-phosphate synthase subunit PDX1.3 (E.C.4.3.3.6) |
5LNW | Q8L940 | Crystal structure of Arabidopsis thaliana Pdx1-I320-G3P complex | Pyridoxal 5'-phosphate synthase subunit PDX1.3 (E.C.4.3.3.6) |
2F5V | Q8J136 | Reaction geometry and thermostability mutant of pyranose 2-oxidase from the white-rot fungus Peniophora sp. | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MIG | Q6QWR1 | Pyranose 2-oxidase from Phanerochaete chrysosporium, recombinant wild type | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOE | Q7ZA32 | Pyranose 2-oxidase H450G mutant with 3-fluorinated glucose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOF | Q7ZA32 | Pyranose 2-oxidase H450G mutant with 2-fluorinated glucose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOG | Q7ZA32 | Pyranose 2-oxidase V546C mutant with 3-fluorinated glucose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOH | Q7ZA32 | Pyranose 2-oxidase V546C mutant with 2-fluorinated glucose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOI | Q7ZA32 | Pyranose 2-oxidase H450G/V546C double mutant with 3-fluorinated glucose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOJ | Q7ZA32 | Pyranose 2-oxidase H450G/V546C double mutant with 2-fluorinated glucose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOM | Q7ZA32 | Pyranose 2-oxidase H450G mutant with 3-fluorinated galactose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOO | Q7ZA32 | Pyranose 2-oxidase H450G mutant with 2-fluorinated galactose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOP | Q7ZA32 | Pyranose 2-oxidase V546C mutant with 3-fluorinated galactose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOQ | Q7ZA32 | Pyranose 2-oxidase V546C mutant with 2-fluorinated galactose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOR | Q7ZA32 | Pyranose 2-oxidase H450G/V546C double mutant with 3-fluorinated galactose | Pyranose 2-oxidase (E.C.1.1.3.10) |
4MOS | Q7ZA32 | Pyranose 2-oxidase H450G/V546C double mutant with 2-fluorinated galactose | Pyranose 2-oxidase (E.C.1.1.3.10) |
1J8R | Q47450 | BINARY COMPLEX OF THE PAPG RECEPTOR-BINDING DOMAIN BOUND TO GBO4 RECEPTOR | Pyelonephritic adhesin, PAPG RECEPTOR-BINDING DOMAIN |
4QO5 | A8AB33 | Hypothetical multiheme protein | Putative uncharacterized protein |
5DZE | F6I323 | Crystal Structure of the catalytic nucleophile mutant of VvEG16 in complex with cellotetraose | Putative uncharacterized protein |
5ULB | A0A0T9SS21 | Crystal structure of sugar ABC transporter from Yersinia enterocolitica subsp. enterocolitica 8081 | Putative sugar ABC transporter |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024